Abstract
OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 420-433 |
| Number of pages | 14 |
| Journal | American Journal of Roentgenology |
| Volume | 208 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2017 |
Keywords
- FDG PET/CT
- Follow-up
- Lung cancer
- Recurrence detection
- Therapy assessment
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Fingerprint
Dive into the research topics of 'The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS